Nondialyzable versus Dialyzable β -Blockers in Hemodialysis : A Target Trial Emulation Study.
Saved in:
| Title: | Nondialyzable versus Dialyzable β -Blockers in Hemodialysis : A Target Trial Emulation Study. |
|---|---|
| Authors: | Etemadi A; Division of Nephrology, Department of Medicine, Stanford University, Stanford, California., Liu S; Division of Nephrology, Department of Medicine, Stanford University, Stanford, California., Winkelmayer WC; Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas., Montez-Rath ME; Division of Nephrology, Department of Medicine, Stanford University, Stanford, California., Chang TI; Division of Nephrology, Department of Medicine, Stanford University, Stanford, California. |
| Source: | Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2026 May 20. Date of Electronic Publication: 2026 May 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
